| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Research Laboratory, University of California, Berkeley, California 94720 [A. B., S. C., G. B., W. I., J. Y., S. N.], Department of Anatomy, University of California, San Francisco, California 94143 [J. E.], and Department of Surgery, Division of Surgical Oncology, University of Illinois at Chicago, College of Medicine, Chicago, Illinois [C. B., T. D.]
Human breast epithelial cells isolated from normal breast tissues of premenopausal women demonstrated direct evidence of a proliferative effect by linoleate (18:2
6) or prostaglandin E2 (PGE2) in the presence of insulin and epidermal growth factor in serum-free cultures within a collagen gel matrix. Neither epidermal growth factor nor 18:2
6 by itself was capable of stimulating growth but together they stimulated proliferation synergistically. Epithelial cells isolated from fibroadenomas on the other hand failed to exhibit any growth stimulation due to 18:2
6 or PGE2. The linoleate-stimulated growth in normal breast epithelial cells was inhibited by indomethacin, a cyclooxygenase inhibitor, which however could be reversed by PGE2.
The proliferative response of normal breast epithelial cells to 18:2
6 was accompanied by a greater conversion of [14C]18:2
6 to arachidonic acid and [14C]20:4
6 to prostaglandins than that seen in epithelial cells from fibroadenomas. The turnover of [14C]18:2
6 in the phospholipids of normal cells was higher than in fibroadenomas indicating a possible role of phospholipids in mediating the 18:2
6 effect in normal cells.
Both normal and fibroadenoma cells can proliferate in response to cholera toxin and glucocorticoids when supplemented to the insulin- and epidermal growth factor-containing medium. From the results it appears that, unlike normal cells, fibroadenoma cells may have a specific defect in the PGE2-responsive cyclic AMP-generating mechanism whereas cholera toxin-induced mechanism is operative in both types of cells.
1 This work was supported in part by American Cancer Society Grant PDT 252, NIH Grant CA05388, NIH Grant CA40160, and NIH Grant CA09041.
2 To whom requests for reprints should be addressed, at Cancer Research Laboratory, 3510 Life Sciences Building, University of California, Berkeley, CA 94720.
Received 3/28/88. Revised 8/23/88. Revised 11/ 7/88. Accepted 11/10/88.
This article has been cited by other articles:
![]() |
L. D. Yee, D. C. Young, T. J. Rosol, A. M. VanBuskirk, and S. K. Clinton Dietary (n-3) Polyunsaturated Fatty Acids Inhibit HER-2/neu-Induced Breast Cancer in Mice Independently of the PPAR{gamma} Ligand Rosiglitazone J. Nutr., May 1, 2005; 135(5): 983 - 988. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Natarajan, R. Esworthy, W. Bai, J.-L. Gu, S. Wilczynski, and J. Nadler Increased 12-Lipoxygenase Expression in Breast Cancer Tissues and Cells. Regulation by Epidermal Growth Factor J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1790 - 1798. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |